22.03.2024 Katharina Höfer received Otto Meyerhof Prize 2024
The Otto Meyerhof Prize is awarded by the Society for Biochemistry and Molecular Biology (GBM) and sponsored by the Germany-based pharmaceutical global player Boehringer Ingelheim. It is awarded every two years to an outstanding young scientist with a doctorate no longer than eight years past at the time of the application deadline and who is currently conducting research in Germany.
Since 2020, Dr. Katharina Höfer and her research group "Bacterial Epitranscriptomics" at the Max Planck Institute for Terrestrial Microbiology in Marburg have been investigating the function of RNA modifications in bacteria, researching the mechanisms discovered not only from the perspective of basic research, but also with a view to possible future applications.
"As a member of SYNMIKRO, we have many opportunities open to us, for which I am very grateful, be it the connection to chemistry, structural biology or the opportunity to work on different cells, as in our latest collaboration. Interdisciplinarity is essential for innovative, application-oriented research. Marburg is 'the perfect place' to actively advance research into bacterial RNA modifications, and the award motivates and encourages me to continue on this path”, says Katharina Höfer.